As expected, the U.S. Food and Drug Administration (FDA) could not approve the last Wuhan coronavirus (COVID-19) “booster” shots from Pfizer and Moderna fast enough, as the shots are now ready for distribution following agency approval.
Despite a total and complete lack of scientific evidence showing either safety or efficacy, the shots, which CNBC says target the “omicron variant XBB.1.5,” will be available to the public by the time you read this article.
Before the COVIDIOTS will be able to actually get one injected into the arm, though, the U.S. Centers for Disease Control and Prevention (CDC) will need to issue an official recommendation for their use. Only then will the shots be available at pharmacies, clinics, and health care providers.
According to CNBC, these latest COVID jabs are an “updated” version from the previous boosters from Pfizer and Moderna. People in the U.S. aged 12 and older are approved for the new shots, while children six months of age through 11 are authorized under emergency use to get injected.
(Related: Did you know that one of the very serious side effects of COVID “vaccination” is leprosy?)
Once the CDC converges to rubber-stamp its approval for the shots, the Biden regime will be sending them out at warp speed to distribution sites all across America. By the time fall arrives, the new injections will more than likely be ready for mass injection.
As for the COVID booster shot from Novavax, which did not participate in the Trump administration’s Operation Warp Speed program, the FDA has not yet made a decision about that one.
According to reports, the Novavax COVID jab is different from the mRNA COVID jabs from Pfizer and Moderna. It utilizes a protein-based technology that is decades old, having been used in other vaccines such as those for hepatitis B and shingles.
“Meanwhile, Pfizer’s and Moderna’s shots use messenger RNA, which teaches cells how to make proteins that trigger an immune response against Covid,” CNBC explains.
We are told that these new-and-improved shots do not target the dominant variants currently in circulation, though. Pfizer, Moderna, and Novavax all claim that their respective shots will still offer some protection, however, especially as the weather cools down.
“We expect this season’s vaccine to be available in the coming days, pending recommendation from public health authorities,” proclaimed Pfizer CEO Albert Bourla.
As usual, Bourla and his counterpart at Moderna are urging Americans to rush out immediately once the shots become available so they can get jabbed right away. This will ensure that billions of dollars flow into the two companies, further enriching Bourla’s fortune.
Just like they did during COVID 1.0, the corporate media is claiming that hospitalizations are on the rise. And in order to bring them back down, everyone must get injected with the latest COVID boosters.
“The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants,” the FDA said in a release following its decision.
Pfizer, Moderna, and Novavax all claim that “early trial data” suggests their respective injections for COVID provide extra protection against “Eris,” which is what they have named a new alleged circulating strain of the Fauci Flu.
Interestingly, all previous COVID booster shots from Pfizer and Moderna are no longer authorized for use in the U.S. Anyone who goes out to get jabbed for COVID in the coming days will only have access to the newest boosters.
The FDA has gone rogue and needs to be immediately stripped of its power. Learn more at FDA.news.
Sources for this article include:
Biden, Big Pharma, CDC, Centers for Disease Control and Prevention, chemical violence, COVID, covid-19, FDA, Food and Drug Administration, Moderna, omicron, Operation Warp Speed, Pfizer, pharma fraud, science deception, vaccination, vaccine, xbb.1.5
This article may contain statements that reflect the opinion of the author
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.